| P50 | author | Ivonne Hernandez Schulman | Q58875451 |
| P2093 | author name string | Joshua M Hare | |
| | Viky Y Suncion | |
| | Kartik S Telukuntla | |
| P2860 | cites work | Intracoronary Bone Marrow–Derived Progenitor Cells in Acute Myocardial Infarction | Q22250889 |
| | Stem cell treatment for acute myocardial infarction | Q24203736 |
| | Role of cardiac stem cells in cardiac pathophysiology: a paradigm shift in human myocardial biology | Q26858965 |
| | Mesenchymal stem cells: biology, pathophysiology, translational findings, and therapeutic implications for cardiac disease | Q26865070 |
| | Low-energy shock wave for enhancing recruitment of endothelial progenitor cells: a new modality to increase efficacy of cell therapy in chronic hind limb ischemia | Q28582868 |
| | Mesenchymal stem cells in health and disease | Q29614296 |
| | Mesenchymal stem cells reside in virtually all post-natal organs and tissues | Q29617740 |
| | Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomised phase 1 trial | Q29620043 |
| | RETRACTED: Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial | Q29620044 |
| | Adult cardiac stem cells are multipotent and support myocardial regeneration | Q29620122 |
| | Guided cardiopoiesis enhances therapeutic benefit of bone marrow human mesenchymal stem cells in chronic myocardial infarction | Q30496413 |
| | Bone marrow mesenchymal stem cells stimulate cardiac stem cell proliferation and differentiation | Q30523741 |
| | Aging impairs the angiogenic response to ischemic injury and the activity of implanted cells: combined consequences for cell therapy in older recipients | Q30909219 |
| | Profoundly reduced neovascularization capacity of bone marrow mononuclear cells derived from patients with chronic ischemic heart disease | Q33200016 |
| | Improved clinical outcome after intracoronary administration of bone-marrow-derived progenitor cells in acute myocardial infarction: final 1-year results of the REPAIR-AMI trial | Q33263365 |
| | Stem cells in the dog heart are self-renewing, clonogenic, and multipotent and regenerate infarcted myocardium, improving cardiac function | Q33863225 |
| | The Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) trial: first randomized placebo-controlled study of myoblast transplantation. | Q34010010 |
| | Effect of shock wave-facilitated intracoronary cell therapy on LVEF in patients with chronic heart failure: the CELLWAVE randomized clinical trial | Q38452816 |
| | Human versus porcine mesenchymal stromal cells: phenotype, differentiation potential, immunomodulation and cardiac improvement after transplantation | Q41948638 |
| | Intramyocardial stem cell injection in patients with ischemic cardiomyopathy: functional recovery and reverse remodeling | Q42226249 |
| | Stem cells and myocardial regeneration: cooperation wins over competition | Q42917118 |
| | What is the oncologic risk of stem cell treatment for heart disease? | Q43203972 |
| | Selective functional exhaustion of hematopoietic progenitor cells in the bone marrow of patients with postinfarction heart failure | Q44270472 |
| | Molecular and cellular characterisation of highly purified stromal stem cells derived from human bone marrow. | Q45859658 |
| | Intramyocardial injection of autologous cardiospheres or cardiosphere-derived cells preserves function and minimizes adverse ventricular remodeling in pigs with heart failure post-myocardial infarction | Q46259595 |
| | Assessment of myocardial viability in reperfused acute myocardial infarction using 16-slice computed tomography in comparison to magnetic resonance imaging | Q46553132 |
| | A novel monoclonal antibody (STRO-3) identifies an isoform of tissue nonspecific alkaline phosphatase expressed by multipotent bone marrow stromal stem cells | Q46833564 |
| | Regenerative potential of cardiosphere-derived cells expanded from percutaneous endomyocardial biopsy specimens. | Q48414650 |
| | Dose-dependent contribution of CD34-positive cell transplantation to concurrent vasculogenesis and cardiomyogenesis for functional regenerative recovery after myocardial infarction | Q48619654 |
| | The significant cardiomyogenic potential of human umbilical cord blood-derived mesenchymal stem cells in vitro. | Q50684064 |
| | Analysis of tissues following mesenchymal stromal cell therapy in humans indicates limited long-term engraftment and no ectopic tissue formation. | Q53171235 |
| | CD34(+) cell infusion after ST elevation myocardial infarction is associated with improved perfusion and is dose dependent. | Q53254720 |
| | Allogenicity of human cardiac stem/progenitor cells orchestrated by programmed death ligand 1. | Q54465293 |
| | Cell-based therapy for myocardial repair in patients with acute myocardial infarction: Rationale and study design of the SWiss multicenter Intracoronary Stem cells Study in Acute Myocardial Infarction (SWISS-AMI) | Q54806428 |
| | Cardiopoietic Stem Cell Therapy in Heart Failure | Q57779306 |
| | Reparative Effects of Allogeneic Mesenchymal Precursor Cells Delivered Transendocardially in Experimental Nonischemic Cardiomyopathy | Q58865316 |
| | Enrichment for STRO-1 expression enhances the cardiovascular paracrine activity of human bone marrow-derived mesenchymal cell populations | Q59696056 |
| | Regenerating functional myocardium: Improved performance after skeletal myoblast transplantation | Q61776512 |
| | Prediction of mortality and morbidity with a 6-minute walk test in patients with left ventricular dysfunction. SOLVD Investigators | Q70508775 |
| | Young adult bone marrow-derived endothelial precursor cells restore aging-impaired cardiac angiogenic function | Q74211099 |
| | Mesenchymal stem cell implantation in a swine myocardial infarct model: engraftment and functional effects | Q74341231 |
| | HLA expression and immunologic propertiesof differentiated and undifferentiated mesenchymal stem cells | Q79149793 |
| | CD34-positive cells exhibit increased potency and safety for therapeutic neovascularization after myocardial infarction compared with total mononuclear cells | Q79317344 |
| | Adipose tissue stromal cells transplantation in rats of acute myocardial infarction | Q80147613 |
| | Isolation and expansion of adult cardiac stem cells from human and murine heart | Q80837204 |
| | Intracoronary administration of autologous adipose tissue-derived stem cells improves left ventricular function, perfusion, and remodelling after acute myocardial infarction | Q81435055 |
| | T cell responses to allogeneic human mesenchymal stem cells: immunogenicity, tolerance, and suppression | Q81704121 |
| | Controlled delivery of basic fibroblast growth factor promotes human cardiosphere-derived cell engraftment to enhance cardiac repair for chronic myocardial infarction | Q82750318 |
| | Skeletal myoblasts for cardiac repair: Act II? | Q82750332 |
| | Rationale and design of the Transendocardial Injection of Autologous Human Cells (bone marrow or mesenchymal) in Chronic Ischemic Left Ventricular Dysfunction and Heart Failure Secondary to Myocardial Infarction (TAC-HFT) trial: A randomized, double | Q83582313 |
| | Exogenous basic fibroblast growth factor promotes cardiac stem cell-mediated myocardial regeneration after miniswine acute myocardial infarction | Q83665843 |
| | Mixed results for bone marrow–derived cell therapy for ischemic heart disease | Q85334667 |
| | Cardiosphere-derived cells improve function in the infarcted rat heart for at least 16 weeks--an MRI study | Q34063589 |
| | Effect of intracoronary delivery of autologous bone marrow mononuclear cells 2 to 3 weeks following acute myocardial infarction on left ventricular function: the LateTIME randomized trial | Q34074673 |
| | Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy. | Q34228118 |
| | Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial | Q34332467 |
| | Effect of the use and timing of bone marrow mononuclear cell delivery on left ventricular function after acute myocardial infarction: the TIME randomized trial | Q34467911 |
| | Relative roles of direct regeneration versus paracrine effects of human cardiosphere-derived cells transplanted into infarcted mice. | Q35050037 |
| | Cardiac cell therapy: where we've been, where we are, and where we should be headed | Q35144550 |
| | Fundamental concepts in myocardial viability assessment revisited: when knowing how much is "alive" is not enough | Q35632156 |
| | CT for evaluation of myocardial cell therapy in heart failure: a comparison with CMR imaging | Q35632921 |
| | Safety and efficacy of allogeneic cell therapy in infarcted rats transplanted with mismatched cardiosphere-derived cells | Q35666637 |
| | Direct comparison of different stem cell types and subpopulations reveals superior paracrine potency and myocardial repair efficacy with cardiosphere-derived cells | Q35799278 |
| | Human cardiac stem cells | Q35956924 |
| | Cardiovascular magnetic resonance characterization of peri-infarct zone remodeling following myocardial infarction | Q35959779 |
| | Cell-based therapy for prevention and reversal of myocardial remodeling | Q36176132 |
| | Administration of cardiac stem cells in patients with ischemic cardiomyopathy: the SCIPIO trial: surgical aspects and interim analysis of myocardial function and viability by magnetic resonance | Q36252910 |
| | Stem cells, ageing and the quest for immortality. | Q36523915 |
| | Comparison of allogeneic vs autologous bone marrow–derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: the POSEIDON randomized trial | Q36603453 |
| | Enhanced effect of combining human cardiac stem cells and bone marrow mesenchymal stem cells to reduce infarct size and to restore cardiac function after myocardial infarction | Q36630155 |
| | A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction | Q36634299 |
| | Effect of transendocardial delivery of autologous bone marrow mononuclear cells on functional capacity, left ventricular function, and perfusion in chronic heart failure: the FOCUS-CCTRN trial | Q36694346 |
| | Is functional improvement after myocardial infarction predicted with myocardial enhancement patterns at multidetector CT? | Q36906566 |
| | The potential of umbilical cord blood multipotent stem cells for nonhematopoietic tissue and cell regeneration | Q36976177 |
| | Concise review: the role of clinical trials in deciphering mechanisms of action of cardiac cell-based therapy | Q37056280 |
| | Loss of p53 induces tumorigenesis in p21-deficient mesenchymal stem cells | Q37133940 |
| | Cardiac repair and regeneration: the Rubik's cube of cell therapy for heart disease | Q37253735 |
| | Allogeneic mesenchymal stem cells restore cardiac function in chronic ischemic cardiomyopathy via trilineage differentiating capacity. | Q37310724 |
| | Local activation or implantation of cardiac progenitor cells rescues scarred infarcted myocardium improving cardiac function | Q37355668 |
| | Autologous mesenchymal stem cells produce reverse remodelling in chronic ischaemic cardiomyopathy | Q37420332 |
| | Myocardial infarction and intramyocardial injection models in swine | Q37606101 |
| | What's new in cardiac cell therapy? Allogeneic bone marrow stromal cells as "universal donor cells". | Q37690845 |
| | Stem cells for heart failure in the aging heart | Q37708148 |
| | Multipotent mesenchymal stromal cell therapy and risk of malignancies | Q37975113 |
| | Adult bone marrow cell therapy improves survival and induces long-term improvement in cardiac parameters: a systematic review and meta-analysis | Q38021450 |
| | Translational findings from cardiovascular stem cell research | Q38039764 |
| P275 | copyright license | Creative Commons Attribution-NonCommercial | Q6936496 |
| P433 | issue | 5 | |
| P921 | main subject | heart disease | Q190805 |
| | cell transplantation | Q65592860 |
| | biomedical investigative technique | Q66648976 |
| P304 | page(s) | e000338 | |
| P577 | publication date | 2013-10-10 | |
| P1433 | published in | Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease | Q19880670 |
| P1476 | title | The advancing field of cell-based therapy: insights and lessons from clinical trials | |
| P478 | volume | 2 | |